Description
Poster Topics: DIABETES/ENDOCRINE - Cost Studies

Garcia Sanchez JJ1, Willis M2, Nilsson A2, Ericson O2, Ball P1, Dunlop W3
1Mundipharma International, Cambridge, UK, 2The Swedish Institute for Health Economics, Lund, Sweden, 3Mundipharma International Ltd, Cambridge, UK


To view the poster abstract visit:
ESTIMATED EVENTS AVOIDED AND COST OFFSETS ASSOCIATED WITH USING CANAGLIFLOZIN TO TREAT PATIENTS WITH TYPE TWO DIABETES MELLITUS (T2DM) WITH OR AT HIGH RISK OF DEVELOPING CARDIOVASCULAR DISEASE (CVD) IN ENGLAND

Agenda
Poster

Posters

8:45 AM–1:30 PM Nov 13, 2018